Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9-10
|
pubmed:dateCreated |
1995-11-22
|
pubmed:abstractText |
Irradiated tumor cells genetically modified to secrete granulocyte/macrophage-colony-stimulating factor (GM-CSF tumor vaccine) are potent stimulators of systemic antitumor immunity. For the preparation of a GM-CSF gene-modified tumor vaccine, it is important to achieve efficient genetic transduction of tumor cells, leading to an appropriate expression of the induced gene. In this report, with a view to developing a protocol for an effective cancer vaccination therapy, we examined the vaccination efficacies of tumor cells secreting GM-CSF by either adenovirus- or retrovirus-mediated genetic transduction. By using an adenoviral vector, Adex1CAmGMCSF, a highly efficient gene delivery and a high-level expression of the GM-CSF gene were achieved. Unexpectedly, animal vaccination studies showed that the GM-CSF tumor vaccine transduced with the Adex1CAmGMCSF recombinant adenovirus (adenoviral GM-CSF tumor vaccine) was less efficacious than that transduced with the MFGmGMCSF recombinant retrovirus (retroviral GM-CSF tumor vaccine). The GM-CSF serum concentration attained by the adenoviral GM-CSF tumor vaccine was much higher than that obtained by the retroviral GM-CSF tumor vaccine. Our findings indicate that an optimal level of GM-CSF production is important for the tumor vaccine to elicit an adequate response in the host antitumor immunity.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0171-5216
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
121
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
587-92
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7559742-Adenoviridae,
pubmed-meshheading:7559742-Animals,
pubmed-meshheading:7559742-Female,
pubmed-meshheading:7559742-Genetic Vectors,
pubmed-meshheading:7559742-Granulocyte-Macrophage Colony-Stimulating Factor,
pubmed-meshheading:7559742-Melanoma, Experimental,
pubmed-meshheading:7559742-Mice,
pubmed-meshheading:7559742-Mice, Inbred C57BL,
pubmed-meshheading:7559742-Recombinant Proteins,
pubmed-meshheading:7559742-Retroviridae,
pubmed-meshheading:7559742-Transduction, Genetic,
pubmed-meshheading:7559742-Tumor Cells, Cultured,
pubmed-meshheading:7559742-Vaccination,
pubmed-meshheading:7559742-Vaccines
|
pubmed:year |
1995
|
pubmed:articleTitle |
Antitumor effect induced by granulocyte/macrophage-colony-stimulating factor gene-modified tumor vaccination: comparison of adenovirus- and retrovirus-mediated genetic transduction.
|
pubmed:affiliation |
Department of Molecular Biotherapy Research, Cancer Chemotherapy Center, Tokyo, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|